Produkty 566-99-4

CAS 566-99-4 występuje w naszej ofercie pod nazwami: Doristerol, Doristerol, >95% (HPLC). Oferty producentów: Chemat Brand, TRC, Biosynth. Dostępne opakowania: on request, 100mg, 10mg, 50mg, 25mg.

Doristerol
Chemat Brand, Biosynth
  • opakowanie: on request, 25mg, 10mg, 50mg
  • Warianty: 5
Zobacz produkt
Doristerol, >95% (HPLC)
TRC
  • opakowanie: 100mg, 10mg, 50mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5S,9R,10S,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CAS 566-99-4) to związek chemiczny o wzorze sumarycznym C27H46O i masie molowej 386.7 g/mol. Nazwa systematyczna IUPAC: (3S,5S,9R,10S,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. InChIKey: ONYPIMNXSARKFQ-NFTYELEKSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H46O
Masa molowa386.7 g/mol
Nazwa IUPAC(3S,5S,9R,10S,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyONYPIMNXSARKFQ-NFTYELEKSA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CCC2=C3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@]12C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Doristerol, 5alpha-Cholest-8(14)-en-3beta-ol, Delta8(14)-Cholestenol, (3beta,5alpha)-Cholest-8(14)-en-3-ol; 5alpha-Cholest-8(14)-ene-3beta-ol, Cholest-8(14)-en-3beta-ol, 5a-cholest-8(14)-en-3b-ol, 5-alpha-cholest-8(14)-en-3beta-ol, 5alpha-Cholest-8(14)-ene-3beta-ol, (3beta,5alpha)-Cholest-8(14)-en-3-ol, 5I+/--Cholest-8(14)-en-3I(2)-ol
Izomery (ten sam wzór sumaryczny)
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C27H46O
(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C27H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-(113C)methyl(4,5,6,7-13C4)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O
(3S,8S,9S,10R,13R,14S,17R)-2,2,3,4,4,6-hexadeuterio-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol C27H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O